Estradiol induces osteoprotegerin expression by human dental pulp cells

Odontology

Volumn 104, Issue 1, 2016, Pages 10-18

  Manokawinchoke, Jeeranan ^a   Ritprajak, Patcharee ^a   Osathanon, Thanaphum ^a   Pavasant, Prasit ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Estrogen; Human dental pulp cells; OPG; RANKL

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

AGONISTS; ANALOGS AND DERIVATIVES; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOOTH PULP; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; DENTAL PULP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; HUMANS; IMMUNOHISTOCHEMISTRY; MAP KINASE SIGNALING SYSTEM; OSTEOPROTEGERIN; PHOSPHORYLATION; RANK LIGAND; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84953357699     PISSN: 16181247     EISSN: 16181255     Source Type: Journal    
DOI: 10.1007/s10266-014-0178-x     Document Type: Article

References (35)

1. Balasch J. Sex steroids and bone: current perspectives. Hum Reprod Update. 2003;9:207–22.
2. Finkelstein JS, Lee H, Burnett-Bowie SM, Pallais JC, Yu EW, Borges LF, Barry CV, Wulczyn KE, Thomas BJ, Leder BZ. Gonadal steroids and body composition strength, and sexual function in men. N Engl J Med. 2013;369:1011–22.
3. Gilles JA, Carnes DL, Dallas MR, Holt SC, Bonewald LF. Oral bone loss is increased in ovariectomized rats. J Endod. 1997;23:419–22.
4. Zhang X, Peng B, Fan M, Bian Z, Chen Z. The effect of estrogen deficiency on receptor activator of nuclear factor kappa B ligand and osteoprotegerin synthesis in periapical lesions induced in rats. J Endod. 2007;33:1053–6.
5. Inaba T, Kobayashi T, Tsutsui TW, Ogawa M, Uchida M, Tsutsui T. Expression status of mRNA for sex hormone receptors in human dental pulp cells and the response to sex hormones in the cells. Arch Oral Biol. 2013;58:943–50.
6. Wang Y, Zheng Y, Wang Z, Li J, Wang Z, Zhang G, et al. 10(-7) m 17beta-oestradiol enhances odonto/osteogenic potency of human dental pulp stem cells by activation of the NF-kappaB pathway. Cell Prolif. 2013;46:677–84.
7. Bord S, Ireland DC, Beavan SR, Compston JE. The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone. 2003;32:136–41.
8. Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473:139–46.
9. Kuntz KA, Brown CE Jr, Legan JJ, Kafrawy AH. An immunohistochemical study of osteoprotegerin in the human dental pulp. J Endod. 2001;27:666–9.
10. Srisawasdi S, Pavasant P. Different roles of dexamethasone on transforming growth factor-beta1-induced fibronectin and nerve growth factor expression in dental pulp cells. J Endod. 2007;33:1057–60.
11. Muincharern W, Louwakul P, Pavasant P, Lertchirakarn V. Effect of fluocinolone acetonide on human dental pulp cells: cytotoxicity, proliferation, and extracellular matrix formation. J Endod. 2011;37:181–4.
12. Kim IY, Kim BC. Seong do H. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines. Cancer Res. 2002;62:5365–9.
13. Lee SI, Kim GT, Kim HJ, Park SH, Kim EC. NOD2 mediates odontoblast differentiation and RANKL expression. J Dent Res. 2014;93:678–84.
14. Zhang D, Yang YQ, Li XT, Fu MK. The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1alpha,25-dihydroxyvitamin D3. Arch Oral Biol. 2004;49:71–6.
15. Belibasakis GN, Meier A, Guggenheim B, Bostanci N. Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells. Microb Pathog. 2011;50:6–11.
16. Liu L, Zhang C, Hu Y, Peng B. Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin. J Endod. 2012;38:943–7.
17. Kim YS, Min KS, Lee HD, Oh HW, Kim EC. Effect of cytosolic phospholipase A2 on proinflammatory cytokine-induced bone resorptive genes including receptor activator of nuclear factor kappa B ligand in human dental pulp cells. J Endod. 2010;36:636–41.
18. Zhu Y, Shang L, Chen X, Kong X, Liu N, Bai Y, et al. Deciduous dental pulp stem cells are involved in osteoclastogenesis during physiologic root resorption. J Cell Physiol. 2013;228:207–15.
19. Belibasakis GN, Rechenberg DK, Zehnder M. The receptor activator of NF-kappaB ligand-osteoprotegerin system in pulpal and periapical disease. Int Endod J. 2013;46:99–111.
20. McAbee J, Li Q, Yu H, Kirkwood KL. Sexual dimorphism in periapical inflammation and bone loss from mitogen-activated protein kinase phosphatase-1 deficient mice. J Endod. 2012;38:1097–100.
21. Dzeletovic B, Grga D, Krsljak E, Stratimirovic D, Brkovic B, Stojic D. Dental pulp blood flow and its oscillations in women with different estrogen status. J Endod. 2012;38:1187–91.
22. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol. 2008;70:165–90.
23. Jukic S, Prpic-Mehicic G, Talan-Hranilovc J, Miletic I, Segovic S, Anic I. Estrogen receptors in human pulp tissue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:340–4.
24. Domoslawski P, Podhorska-Okolow M, Pula B, Lukienczuk T, Dziegiel P. Expression of estrogen and progesterone receptors and Ki-67 antigen in graves’ disease and nodular goiter. Folia Histochem Cytobiol. 2013;51:135–40.
25. Sica G, Wagner PL, Altorki N, Port J, Lee PC, Vazquez MF, Saqi A. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors. Arch Pathol Lab Med. 2008;132:1889–95.
26. Stevis PE, Deecher DC, Suhadolnik L, Mallis LM, Frail DE. Differential effects of estradiol and estradiol-BSA conjugates. Endocrinology. 1999;140:5455–8.
27. Schwartz N, Chaudhri RA, Hadadi A, Schwartz Z, Boyan BD. 17Beta-estradiol promotes aggressive laryngeal cancer through membrane-associated estrogen receptor-alpha 36. Horm Cancer. 2014;5:22–32.
28. Sylvia VL, Walton J, Lopez D, Dean DD, Boyan BD, Schwartz Z. 17 beta-estradiol-BSA conjugates and 17 beta-estradiol regulate growth plate chondrocytes by common membrane associated mechanisms involving PKC dependent and independent signal transduction. J Cell Biochem. 2001;81:413–29.
29. Ronda AC, Vasconsuelo A, Boland R. Extracellular-regulated kinase and p38 mitogen-activated protein kinases are involved in the antiapoptotic action of 17beta-estradiol in skeletal muscle cells. J Endocrinol. 2010;206:235–46.
30. Ronda AC, Buitrago C, Boland R. Role of estrogen receptors, PKC and Src in ERK2 and p38 MAPK signaling triggered by 17beta-estradiol in skeletal muscle cells. J Steroid Biochem Mol Biol. 2010;122:287–94.
31. Prossnitz ER, Maggiolini M. Mechanisms of estrogen signaling via GPR30. Mol Cell Endocrinol. 2009;308:32–8.
32. Reddi D, Brown SJ, Belibasakis GN. Porphyromonas gingivalis induces RANKL in bone marrow stromal cells: involvement of the p38 MAPK. Microb Pathog. 2011;51:415–20.
33. Wang Y, Yan M, Yu Y, Wu J, Yu J, Fan Z. Estrogen deficiency inhibits the odonto/osteogenic differentiation of dental pulp stem cells via activation of the NF-kappaB pathway. Cell Tissue Res. 2013;352:551–9.
34. Scuderi G, Contestabile MT, Gagliano C, Iacovello D, Scuderi L, Avitabile T. Effects of phytoestrogen supplementation in postmenopausal women with dry eye syndrome: a randomized clinical trial. Can J Ophthalmol. 2012;47:489–92.
35. Yang TS, Wang SY, Yang YC, Su CH, Lee FK, Chen SC, et al. Effects of standardized phytoestrogen on Taiwanese menopausal women. Taiwan J Obstet Gynecol. 2012;51:229–35.